SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant discussion following reports that Nvidia has paused evaluating its 18A chipmaking process, a crucial element of Intel's revitalized foundry strategy. However, much of the community is highly skeptical, calling the news old or manipulative, and arguing that 18A was primarily for internal use while future external foundry deals, potentially including Nvidia, are centered on the more advanced 14A node. Many investors express frustration over perceived short-term price suppression, yet maintain long-term confidence in Intel's competitive positioning.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is experiencing extreme volatility and intense investor focus as the market eagerly awaits an imminent FDA PDUFA decision for its life-saving drug, Narsoplimab, to treat TA-TMA. Following a trading halt for news pending, community sentiment is largely optimistic for approval, anticipating a significant price surge fueled by high short interest and the drug's first-in-class status for a condition with no existing treatment. The broader context of the recent de-risking deal with Novo Nordisk and previous regulatory hurdles fuels speculation of substantial long-term value and even a potential buyout, making this a pivotal moment for the company.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following the successful orbital launch of its BlueBird 6 satellite, which is touted as the largest commercial communications array ever deployed in low Earth orbit. This achievement is fueling significant bullish sentiment, with many anticipating the validation of its direct-to-device cellular broadband vision and rapid network expansion. However, discussions also reflect skepticism around the company's long-term profitability and current valuation, even as the community focuses on future scaling and execution milestones.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending amidst intensified speculation for a major partnership or buyout, catalyzed by a recent acquisition in the biotech sector and heightened discussions around its undervalued protein-based vaccine platform and combination influenza/COVID candidate. Shareholders are openly frustrated with management's perceived inaction and lack of communication, echoing an activist investor's push for a strategic review to unlock value from Novavax's differentiated non-mRNA technology, especially as concerns about mRNA vaccine safety grow. This confluence of factors, coupled with high short interest, positions the company for potentially significant market movement should a transformative deal be announced.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies is a major talking point as Sanofi announced its acquisition for $15.50 per share, valuing the company at $2.2 billion and representing a substantial premium. This move integrates Dynavax's marketed adult Hepatitis B vaccine, its shingles candidate, and a recently licensed oral COVID-19 vaccine program into Sanofi's global immunization portfolio. While many long-term shareholders are relieved to see a resolution, a significant portion of the community feels the acquisition price undervalues the company's assets and growth prospects.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as the market assesses its recently completed Marigold acquisition and updated strong guidance for future financial performance. Community discussions highlight optimism for its advanced AI platform and proprietary data in the evolving marketing sector, with many anticipating significant upside following its participation in an upcoming key industry event. Despite some short-term price fluctuations, investors are closely watching for its potential re-rating as an an undervalued AI-driven marketing powerhouse.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following the FDA's expanded approval of AQVESME (mitapivat) for adults with alpha- or beta-thalassemia, establishing it as the first and only oral treatment for this condition. The community is actively discussing the commercial implications and the drug's high cost, while also reflecting on broader concerns about management's communication style and historical execution.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is experiencing significant positive momentum, driven by its upcoming inclusion in the S&P MidCap 400 index, effective early next year. The community views this as a major catalyst for structural demand, anticipating increased institutional buying, enhanced liquidity, and greater visibility for the Agentic AI and automation leader.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust is surging to new all-time highs, driven by intensifying industrial demand from rapidly expanding sectors like AI data centers, EVs, and solar, alongside significant global supply concerns. The rally is further fueled by China's impending export restrictions on silver, with market participants eagerly discussing a potential 'silver squeeze' and a fundamental re-evaluation of its value, though some anticipate a near-term correction after its rapid ascent.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is heavily trending amid widespread speculation of an imminent buyout, fueled by recent significant insider purchases and strong financial fundamentals including growing Lupkynis sales and a robust cash position. The community is actively discussing the potential Phase 2 indications for AUR200, while many shareholders voice frustration over perceived management opacity and repeatedly call for a change in leadership to unlock further value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phoenix Motor Inc. (19% increase in followers)Anaheim, California-based Phoenix Motor makes electric buses and trucks for various service and government fleet markets.&nbsp;This year, the company drew considerable attention after reporting encouraging fiscal third-quarter results in February that showed revenue soaring by 1,557% to $4.77 million even as net losses widened.&nbsp;After posting these results, which were delayed earlier, it regained compliance with the Nasdaq listing.In February, the company established EdisonFuture International, a Hong Kong-based subsidiary focused on expanding its EV business globally, targeting markets in the Caribbean, South America, Europe, and Asia.&nbsp;For 2024, Phoenix Motor projects revenue of $30 million to $31 million, a tenfold increase from $3 million in 2023. It expects to turn profitable after reporting a net loss in the prior year,&nbsp;with revenue for fiscal year 2025 forecasted to be in the $40 million to $50 million range.Additionally, the company's board approved a $5 million share repurchase program last week.Phoenix Motor's stock has gained 9.5% this year.Chijet Motor Company Inc. (13% increase in followers)Chijet, a Chinese developer of next-generation electric vehicles, has not had any significant news catalysts this year.&nbsp;Last month, the company received a staff determination letter from Nasdaq, notifying Chijet of its impending delisting from the Nasdaq Global Market.&nbsp;The decision came after Chijet failed to regain compliance with the exchange's minimum market value requirements: $50 million for listed securities and $15 million for publicly held shares.During its listing on the Nasdaq in June 2023, Chijet said it has a pipeline of more than a dozen new vehicles and aims to launch its FB77, a pure electric sedan, and the R9 PHEV hybrid SUV in the coming years.The company had said that future models, including the FV20, FB21, and FB31, will span both commercial and passenger segments.Chijet's stock has lost over 20% this year.Zeekr Intelligent Technology Holding (10% increase in followers)Chinese electric vehicle maker Zeekr has been making headlines this year with strong monthly delivery numbers and reports of new premium launches.&nbsp;The Geely-owned automaker's own brand sales surged 86.9% year-over-year in February, and the recent Lynk &amp; Co acquisition boosted total deliveries.&nbsp;Zeekr is also set to unveil the ultra-luxury 9X Grand SUV this month in China, targeting high-end consumers and taking on brands like Mercedes-Benz and BMW.Zeekr stock has lost over 13% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Visitors check ZEEKR 7X cars displayed at the 46th Bangkok International Motor Show 2025 in Nonthaburi province on the outskirts of Bangkok, Thailand, on March 28, 2025. (Photo by Anusak Laowilas/NurPhoto via Getty Images)

Phoenix Motor, Chijet, Zeekr: Retail Traders Flocked To These 3 Auto Stocks The Most In Q1

Although companies such as Tesla, Rivian and legacy automakers such as Ford and GM have dominated headlines this year, these lesser known brands captivated Stocktwits users more in Q1 2025. 

Equity

These five automobile-linked stocks notched the biggest jump in retail following on Stocktwits in the week ended Feb. 14, 2025:WeRide Inc. (+460% jump in following)Chinese self-driving startup WeRide surged to a record high after an SEC filing&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wrd-stock-hits-record-high-on-nvidia-stake/ch5iISdRHD">revealed</a> that AI chip giant Nvidia had taken a stake, owning 1.7 million shares.&nbsp;According to The Fly, Morgan Stanley called the move a sign of growing investor enthusiasm for self-driving technology and the value of strategic alliances in the robotaxi space. The research firm has an 'Overweight' rating and a $23 price target on the stock, which is up 122% year-to-date (YTD).Phoenix Motor Inc. (+14% jump in following)Phoenix Motor regained Nasdaq compliance after resolving delays in its SEC filings, giving the stock a lift. Earlier in the week, the company posted fiscal third-quarter revenue of $4.8 million, up sharply from just $0.2 million a year earlier. It cited the successful integration of its transit segment and partnerships in AI and autonomous tech.&nbsp;Shares are up 25% YTD.Strattec Security Corporation (+8% jump in following)Auto security supplier Strattec continued its rally, likely fueled by strong earnings earlier in the month. Fiscal second-quarter net sales rose 9.6% to $129.9 million, beating estimates, driven by new program launches and rising volumes from key customers like GM and Ford. While sales to Stellantis lagged, demand was strong in North America, particularly from Hyundai.Shares are up nearly 19% YTD.Hesai Group (+5% jump in following)Lidar maker Hesai announced a deeper collaboration with Chinese EV giant BYD, providing lidar for more than 10 upcoming BYD models set for mass production in 2025. BYD, which sold over 4 million intelligent-driving-equipped vehicles last year, is integrating Hesai’s lidar into its next-gen “God’s Eye” ADAS system, expected to expand self-driving features across its lineup.&nbsp;Hesai’s stock is up over 29% YTD.Motorcar Parts of America (+2.5% jump in following)Motorcar Parts reported strong fiscal Q3 results as it swung to a profit, with revenue rising to $186.2 million from $171.9 million last year. CEO Selwyn Joffe highlighted the company’s leadership in the non-discretionary aftermarket parts sector and its focus on quality and customer service.&nbsp;Shares are up 24% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the WeRide, Inc. logo is displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Top 5 Auto Stocks That Had Retail Traders Revved Up Last Week

From AI giants taking a stake to earnings beats, these auto-linked stocks saw the biggest surge in new Stocktwits followers.

Phoenix Motor, Inc. designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium duty electric vehicles, with an aim to reduce carbon intensity and greenhouse gas emissions. It operates under the brands Phoenix Motorcars, which is focused on commercial products including medium duty electric vehicles, chargers, and electric forklifts, and EdisonFuture, which intends to offer light-duty electric vehicles. The company was founded in 2003 and is headquartered in Anaheim, CA.

PEV
Phoenix Motor Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PEV News

PEV Phoenix Motor Inc